ReviewCurrent rheumatology reports2013
Epidemiology of spondyloarthritis: a review.
Review in Current rheumatology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis.Clinical rheumatology · 2016Pooled it
- [How frequent are musculoskeletal diseases in Germany?].Zeitschrift fur Rheumatologie · 2016Pooled it
- Management of U.S. Veterans presenting with axial spondyloarthritis to a chiropractic clinic: a case series.The Journal of the Canadian Chiropractic Association · 2026Article
- A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient.Rheumatology and therapy · 2026Review
- Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results.Archives of rheumatology · 2024Article
- Review
- Burden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients.Reumatologia · 2024Article
- Revisiting articular syndrome in the peri-pandemic COVID-19 era.Rheumatology international · 2023Review
- Seronegative spondyloarthropathy-associated inflammatory bowel disease.World journal of gastroenterology · 2023Review
- Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19Clinical rheumatology · 2022Article
- Epidemiology and Characteristics of Spondyloarthritis in the Predominantly Afro-Descendant Population of Martinique, a French Caribbean Island.Journal of clinical medicine · 2022Article
- The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study.Rheumatology and therapy · 2022Article
- Clinical Manifestations and Diagnosis of Axial Spondyloarthritis.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2021Review
- The association of anti-CD74 antibody with spondyloarthropathies.European journal of rheumatology · 2021Article
- The usefulness and validity of English-language videos on YouTube as an educational resource for spondyloarthritis.Clinical rheumatology · 2021Article
- Haptoglobin and Its Related Protein, Zonulin-What Is Their Role in Spondyloarthropathy?Journal of clinical medicine · 2021Review
- Predicting functional disability in patients with spondyloarthritis using a CRP-based algorithm: A 3-year prospective study.Experimental and therapeutic medicine · 2021Article
- Understanding the Pathogenesis of Spondyloarthritis.Biomolecules · 2020Review
- Prevalence of axial spondyloarthritis in Poland.Rheumatology international · 2020Article
- [Physical activity, exercise and nutrition in rheumatism : Adjuvant treatment options for inflammatory-rheumatic diseases].Der Orthopade · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The classification of Spondyloarthritis (SpA) has been revised with the introduction of the ASAS classification criteria. Although this has best been described in ankylosing spondylitis and psoriatic arthritis, there are population studies evaluating the epidemiology of the different subgroups of SpA. In this paper, we present data on the incidence and prevalence of the subgroups of SpA in different populations, and point to data indicating how the introduction of new classification criteria, with the altered perception of the SpA entity, might impact on the epidemiology.
Indexed as
Identifiers
23888360What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.